An Overview Showing Recent Studies on Nano Medicines for the Treatment of Hyperlipidemia (Review Article)

Author(s): Mohammad Bakhatwar*, Sumant Saini and Boddu Prathyusha

Abstract: Hyperlipidemia refers to a group of inherited and acquired illnesses that are characterized by high lipid levels in the body. It has been established that high cholesterol and LDL in the blood are the primary causes of atherosclerotic arteries, while high concentrations of HDL in the blood are beneficial. Many drug are available to lower the lipid level but they are associated with lots of side effects like myopathy, rhabdomyolysis, myalgia and arthralgia, to overcome this problem there are many oral conventional dosage forms. But there is a problem associated with that is poor bioavailability. In order to overcome that bioavailability problem associated with the less soluble drugs there are some novel drug delivery systems which can be formulated as nano medicines with novel nano techniques employed to enhance the pharmacokinetic parameters of the antihyperlipidemic drugs. The present review includes an overview showing recent studies on nano medicines for the treatment of hyperlipidemia.

PAGES: 56-82  |  191 VIEWS  199 DOWNLOADS